Return to search

The role of tissue kallikrein in helicobacter pylori-associated gastric disease

Submitted in partial fulfillment of the requirement for the Degree of Master of Technology: Biological Sciences, ML Sultan Technikon, 1999. / Today, the number one income-generating drugs are remedies prescribed for gastric disorders, in particular dyspepsia. These clinical conditions have a multi-faceted aetiology and pathology of dysfunction. One likely causal factor is the entero-pathogen Helicobacter pylori. It has been shown to be more than just a commensal related to gastric diseases like dyspepsia (80-90% incidence) and duodenal ulcer sufferers (100% incidence), with a total estimated world-wide population infection of 50%. The current therapy offered to dyspepsia sufferers is a triple regimen of an anti-bacterial, an Ir proton-pump inhibitor, and bismuth colloidal salts. / M

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:dut/oai:ir.dut.ac.za:10321/2779
Date January 1999
CreatorsNaidoo, Strinivasen
ContributorsBhoola, K. D.
Source SetsSouth African National ETD Portal
LanguageEnglish
Detected LanguageEnglish
TypeThesis
Format291 p

Page generated in 0.0019 seconds